Insider · CIK 0001604874

Latham John A

CIK 0001604874 Name as filed on the most recent filing

Filed as Latham John A (27)

43 transaction lines · from 27 filings · filed 2015-01-28 to 2018-11-05 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

43 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2018-11-01 S, Open-market sale Alder Biopharmaceuticals IncALDR 2 lines 335,589, disposed Open Form 4 filing 0001209191-18-057261
2018-10-01 S, Open-market sale Alder Biopharmaceuticals IncALDR 2 lines 386,006, disposed Open Form 4 filing 0001209191-18-054084
2018-09-04 S, Open-market sale Alder Biopharmaceuticals IncALDR 449,680, disposed Open Form 4 filing 0001209191-18-049870
2018-08-01 S, Open-market sale Alder Biopharmaceuticals IncALDR 488,768, disposed Open Form 4 filing 0001209191-18-045039
2018-07-02 S, Open-market sale Alder Biopharmaceuticals IncALDR 387,002, disposed Open Form 4 filing 0001209191-18-041228
2018-06-01 S, Open-market sale Alder Biopharmaceuticals IncALDR 2 lines 446,356, disposed Open Form 4 filing 0001209191-18-035876
2016-12-01 S, Open-market sale Alder Biopharmaceuticals IncALDR 2 lines 82,812, disposed Open Form 4 filing 0001209191-16-153488
2016-11-09 S, Open-market sale Alder Biopharmaceuticals IncALDR 301,839, disposed Open Form 4 filing 0001209191-16-149937
2016-10-03 S, Open-market sale Alder Biopharmaceuticals IncALDR 2 lines 313,152, disposed Open Form 4 filing 0001209191-16-145133
2016-09-01 S, Open-market sale Alder Biopharmaceuticals IncALDR 324,949, disposed Open Form 4 filing 0001209191-16-140254
2016-08-01 S, Open-market sale Alder Biopharmaceuticals IncALDR 2 lines 198,464, disposed Open Form 4 filing 0001209191-16-135308
2016-08-01 S, Open-market sale Alder Biopharmaceuticals IncALDR 113,484, acquired Open Form 4 filing 0001209191-16-135308
2016-07-27 S, Open-market sale Alder Biopharmaceuticals IncALDR 277,023, disposed Open Form 4 filing 0001209191-16-134343
2016-07-26 S, Open-market sale Alder Biopharmaceuticals IncALDR 24,392, disposed Open Form 4 filing 0001209191-16-134343
2016-06-01 S, Open-market sale Alder Biopharmaceuticals IncALDR 300,216, disposed Open Form 4 filing 0001209191-16-125838
2016-05-31 S, Open-market sale Alder Biopharmaceuticals IncALDR 1,009,284, disposed Open Form 4 filing 0001209191-16-124854
2016-05-27 S, Open-market sale Alder Biopharmaceuticals IncALDR 192,335, disposed Open Form 4 filing 0001209191-16-124854
2016-01-04 S, Open-market sale Alder Biopharmaceuticals IncALDR 2 lines 314,137, disposed Open Form 4 filing 0001209191-16-090201
2015-12-01 S, Open-market sale Alder Biopharmaceuticals IncALDR 169,452, disposed Open Form 4 filing 0001209191-15-083418
2015-11-02 S, Open-market sale Alder Biopharmaceuticals IncALDR 3 lines 153,137, disposed Open Form 4 filing 0001209191-15-078577
2015-10-01 S, Open-market sale Alder Biopharmaceuticals IncALDR 2 lines 146,603, disposed Open Form 4 filing 0001209191-15-074112
2015-09-01 S, Open-market sale Alder Biopharmaceuticals IncALDR 2 lines 175,059, disposed Open Form 4 filing 0001209191-15-069524
2015-08-03 S, Open-market sale Alder Biopharmaceuticals IncALDR 207,322, disposed Open Form 4 filing 0001209191-15-064182
2015-07-01 S, Open-market sale Alder Biopharmaceuticals IncALDR 232,381, disposed Open Form 4 filing 0001209191-15-059679
2015-06-04 S, Open-market sale Alder Biopharmaceuticals IncALDR 1,104,463, disposed Open Form 4 filing 0001209191-15-051172
2015-06-01 S, Open-market sale Alder Biopharmaceuticals IncALDR 188,757, disposed Open Form 4 filing 0001209191-15-049865
2015-05-01 S, Open-market sale Alder Biopharmaceuticals IncALDR 116,663, disposed Open Form 4 filing 0001209191-15-039050
2015-04-01 S, Open-market sale Alder Biopharmaceuticals IncALDR 124,609, disposed Open Form 4 filing 0001209191-15-030980
2015-03-30 S, Open-market sale Alder Biopharmaceuticals IncALDR 437,909, disposed Open Form 4 filing 0001209191-15-030980
2015-03-02 S, Open-market sale Alder Biopharmaceuticals IncALDR 119,340, disposed Open Form 4 filing 0001209191-15-022389
2015-01-27 S, Open-market sale Alder Biopharmaceuticals IncALDR 205,278, disposed Open Form 4 filing 0001209191-15-007127
2015-01-26 S, Open-market sale Alder Biopharmaceuticals IncALDR 221,008, disposed Open Form 4 filing 0001209191-15-007127

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 43
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Latham John A, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001604874

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.